Gül, A. Et Al. 2012. Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. ANNALS OF THE RHEUMATIC DISEASES , vol.71 , 563-566.

Gül, A., Tugal-Tutkun, I., Dınarello, C. A., Reznıkov, L., Esen, B. A., Mırza, A., ... Scannon, P.(2012). Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study. ANNALS OF THE RHEUMATIC DISEASES , vol.71, 563-566.

Gül, Ahmet Et Al. "Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study," ANNALS OF THE RHEUMATIC DISEASES , vol.71, 563-566, 2012

Gül, Ahmet Et Al. "Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study." ANNALS OF THE RHEUMATIC DISEASES , vol.71, pp.563-566, 2012

Gül, A. Et Al. (2012) . "Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study." ANNALS OF THE RHEUMATIC DISEASES , vol.71, pp.563-566.

@article{article, author={Ahmet GÜL Et Al. }, title={Interleukin-1 beta-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study}, journal={ANNALS OF THE RHEUMATIC DISEASES}, year=2012, pages={563-566} }